Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lansoprazole in Reflux Laryngitis
NCT00369265Phase 4Terminated
- Sponsor
- American Institute for Voice and Ear Research
- Start
- Aug 2006
- Primary completion
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of lansoprazole in laryngopharyngeal reflux (LPR) (2 arms), sponsored by American Institute for Voice and Ear Research. Primary endpoint: Percentage of Participants With Improvement or Resolution of Arytenoid Erythema at 6 weeks. Started Aug 2006; status: terminated.
02
Drugs
lansoprazole
03
Conditions
laryngopharyngeal reflux (LPR)
Beyond the preview
Go deeper on NCT00369265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00369265.